A drug with the SMILES Cc1c(C(O)CN2CCN(Cc3ccc4c(c3)OCO4)CC2)c2ccccc2n1C has a human ether-à-go-go related gene (hERG) inhibition at 1uM of -45.975\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1c(C(O)CN2CCN(Cc3ccc4c(c3)OCO4)CC2)c2ccccc2n1C
Cc1c(C(O)CN2CCN(Cc3ccc4c(c3)OCO4)CC2)c2ccccc2n1C
[C][C][=C][Branch2][Ring1][S][C][Branch1][C][O][C][N][C][C][N][Branch1][P][C][C][=C][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][O][C][O][Ring1][=Branch1][C][C][Ring1][S][C][=C][C][=C][C][=C][Ring1][=Branch1][N][Ring2][Ring1][N][C]
2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-1-(1,2-dimethylindol-3-yl)ethanol